In vivo antitumor and antimetastatic activity of sunitinib in preclinical neuroblastoma mouse model.

Abstract

Neuroblastoma (NB) is one of the most common pediatric solid tumors originating from the neural crest lineage. Despite intensive treatment protocols including megatherapy with hematopoietic stem cell transplantation, the prognosis of NB patients remains poor. More effective therapeutics are required. High vascularity has been described as a feature of… (More)

Topics

Cite this paper

@article{Zhang2009InVA, title={In vivo antitumor and antimetastatic activity of sunitinib in preclinical neuroblastoma mouse model.}, author={Libo Zhang and Kristen M. Smith and Amy Chong and Diana Stempak and Herman Yeger and Paula M. Marrano and Paul Scott Thorner and Meredith S. Irwin and David R Kaplan and Sylvain Baruchel}, journal={Neoplasia}, year={2009}, volume={11 5}, pages={426-35} }